PatientsVille.com Logo

MALAISE and Cephalexin

PatientsVille

MALAISE Symptoms and Causes

We are sorry, but no medical information on this topic currently exists in our database. Our articles are updated often, please revisit soon.

Check out the latest treatments for MALAISE

➢ MALAISE treatment research studies

➢ Cephalexin clinical trials, surveys and public health registries

Find Drug Side Effect reports



Cephalexin Side Effects

Rash (54)
Pruritus (52)
Diarrhoea (49)
Urticaria (45)
Pain (43)
Vomiting (43)
Dyspnoea (40)
Nausea (40)
Dizziness (34)
Pyrexia (28)
Headache (28)
Abdominal Pain (27)
Deep Vein Thrombosis (26)
Abdominal Pain Upper (23)
International Normalised Ratio Increased (23)
Malaise (22)
Renal Failure Acute (20)
Anxiety (19)
Fatigue (19)
Anaphylactic Reaction (18)
Injury (16)
Rash Pruritic (15)
Chills (15)
Dehydration (14)
Blister (14)
Hypersensitivity (14)
Haemoglobin Decreased (14)
Pulmonary Embolism (14)
Oedema Peripheral (13)
Hypovolaemic Shock (13)
Arthralgia (13)
Angioedema (12)
Asthenia (12)
Gallbladder Disorder (12)
Muscle Spasms (12)
Depression (12)
Erythema (11)
Condition Aggravated (11)
Haematuria (11)
Skin Exfoliation (11)
Liver Function Test Abnormal (11)
Somnolence (11)
Myalgia (10)
Chest Pain (10)
Pain In Extremity (10)
Swelling Face (10)
Urinary Tract Infection (10)
Tremor (10)
Swelling (10)
Weight Decreased (9)

➢ More

Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

After 5 doses - experienced extreme blood shot eyes and a tender head to the touch. Symptoms totally gone after a day&1/2. Wow, didn't see that in the small print.

After being put on this for Bladder Infection..I experience lip swelling about 3 days in. It was not terrible but uncomfortable. I had NO other signs of anything else. If you pulled up and down my lips you could also see some red. I stopped taking af

Also forgot to mention I was put on this bc I am allergic to Sulfa and it is in a lot of bladder infection antibiotics they usually prescribe. Also, there was a chance I could be pregnant so this is why this one was chosen.

Does cephalexin cause weight gain?

Head is in pain 2 day takeing it :(

How long after being started on cephalexin can urticaria occur?

I am currently on Cephalexin for a kidney infection. I have so far suffered from joint pain, headaches, unusual vaginal pain and itching, dizziness and discovered a sore throat this morning. I plan to finish my dose but it seems like I'm suffering wo

I gained 9 pounds in three weeks and has upper abdominal pain.

I had bloody stools after taking cephalexing for like 3 days, i called my doctor and was told to stop taking it for a weekm I started taking cephalexing due to and ear bacteria , they will change treatment after a week , i stopped having bloody stool

I have been taking Cephalexin 500mg for a week due to car wreck elbow injury. Prescribed for possible infection. I am somewhat constipated, and have gained 11 pounds... Is this normal, and will the weight gain go away wh

After taking Cialis I experienced nause and chest discomfort for two days so far, along with a pronounced feeling of general malaise and fatigue.

Bad gastritis or abdominal pain; had to get into tub with hot shower on my belly;never had a worse experience or pain; thought I was going to die; malaise; moderate ear pain

Hi. yes i have the same symptoms. I feel terrible when I wake up in the can. I have lots of back pain, leg pain, general pain and muscle stiffness: a general feeling of malaise and fatigue. After I'm up for little while, I usually feel bett

I have been on Flomaxtra forover a year. During this time I have been experiencing fatigue, low energy and malaise. Has anyone stopped this drug for any alternative methods/drug ?

I have been taking the new, smaller pill for a few weeks now, and finally realized that it's the reason that I've been having this constant nausea, sometimes coupled with headaches, and general feeling of malaise. Haven't taken it for a few days and

I haven't felt generally good since starting Humira 9months ago. Previous to that I had a four month hiatus while the insurance got straightened out. While I'm on it, along with general malaise, I have an acid stomach and nausea a

I'm 31. Only day 2 for me. General feeling of malaise, slightly achy and restless legs and itching all over, developed a rash on right side of torso. Noticed the nausea on taking my tablets (mornings only for now), in spite of full stomach and sudden

Inadequate control of blood sugar, have to starve myself to get lower blood sugar even on two types of insulin, diarrhoea, dizziness, syncope, dyspnoea, severe malaise, nausea, tremors.

My husband experienced nausea, vomiting, malaise, raised creatinine levels, 2.1-2.3, extreme thirst and urination. He filled 5 urinals in the hospital in 12 hours. Diabetes insipidus neph. He also had an elevated eosin l

RECLAST SIDE EFFECTS: I investigated the new drug, Reclast, in advance of my one and only injection in November 2008. After the injection, I became extremely fatigued and developed an overall sense of malaise and misery. I am normally energetic and u

MALAISE Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting Optimal Dosage of Caspofungin in Critically Ill Patients
Conditions: Critically Ill;   Suspected Invasive Candidiasis
Intervention: Drug: Caspofungin
Outcome Measures: The optimal dosage of caspofungin in relation to adequate exposure (measured as AUC) in critically ill patients.;   Pharmacokinetic parameters of caspofungin in critically ill patients.;   Correlation of pharmacokinetic parameters and the plasma concentration of caspofungin with disease severity scores.;   Correlation of the plasma concentration of caspofungin with candida eradication.;   Correlation of the plasma concentration of caspofungin with inflammation parameters.;   AUC/MIC ratio and highest observed plasma concentration (Cmax)/MIC ratio.;   Constructing a pharmacokinetic model of caspofungin in critically ill patients.;   Drug-related adverse events of caspofungin.
2 Unknown † The Effect of Prophylactic Probiotic Lactobacilli in Enteral Feeding on Nosocomial Pneumonia Rates in Critically Ill Patients
Condition: Critical Illness
Intervention: Drug: Probiotic Lactobacillus
Outcome Measures: To determine if enteral feeding plus probiotic Lactobacilli are associated with a reduced rate of nosocomial pneumonia in critically ill patients.;   To determine the incidence of complications of enteral feeding with and without added probiotic Lactobacilli.;   To assess if the efficacy of enteral feeding in critically ill patients is improved by the addition of probiotic Lactobacilli.
3 Not yet recruiting Tissue Near InfraRed Spectroscopy (NIRS) in Critically Ill Patients
Conditions: Sepsis;   Inflammation;   Shock
Intervention:
Outcome Measures: tNIRS Reperfusion slope of VOT;   tNIRS for Management of Critically Ill Patients with Sepsis
4 Recruiting Pancreatic Exocrine Insufficiency and Pancreatic Enzyme Supplementation in Critically Ill Adult Patients
Conditions: Critical Illness;   Sepsis;   Diabetes;   Cardiac Arrest;   Acute Renal Failure;   Shock
Intervention: Dietary Supplement: Enteral nutrition (EN)
Outcome Measures: Screening and risk factors of exocrine pancreatic insufficiency in critically ill adult patients receiving enteral nutrition;   Effects of pancreatic enzyme supplementation on nutritional status and clinical outcomes in critically ill patients with sepsis
5 Recruiting Transplanted-like Heart in Critical Ill Patients
Condition: Autonomic Nervous System Dysfunction in Critically Ill
Intervention: Other: Gravitational sympathetic stimulus
Outcome Measures: Incidence of autonomic nervous system dysfunction in critical ill patients;   to measure the occurrence of ANS failure in subgroups;   Length of stay in ICU and in Hospital;   mortality;   days free from mechanical ventilation
6 Recruiting Effects of AN69 ST Hemofilter on Coagulation During Continuous Renal Replacement Therapy in Critically Ill
Conditions: Critically Ill;   Acute Kidney Injury;   Septic Shock
Interventions: Device: AN 69 ST hemofilter;   Device: AN 69 hemofilter
Outcome Measures: The using time of hemofilters;   activated partial thromboplastin time
7 Recruiting Prevention of Nosocomial Infections in Critically Ill Patients With Lactoferrin: The PREVAIL Study
Condition: Critically Ill
Interventions: Dietary Supplement: Lactoferrin;   Other: Placebo
Outcome Measures: Antibiotic free days.;   Feasibility of conducting a Phase 3 study powered on clinically important outcomes such as mortality, length of stay and duration of mechanical ventilation.
8 Unknown † Family Involvement in The Treatment Of a Mentally Ill Relative
Condition: Families of Mentally Ill
Intervention: Behavioral: filling the "Experience of Caregiving Inventory"
Outcome Measure: Score on the "Experience of Caregiving Inventory" following 8 weeks of participation in the group.
9 Recruiting 2012_PharmacoCRRT-study:Pharmacokinetics of Anti-infectives /Antibiotics in Critically Ill Patients in Need of Continuous Renal Replacement Therapy (CRRT)
Conditions: Critically Ill;   Acute Renal Failure;   Acute Kidney Injury
Intervention:
Outcome Measure: Sub-therapeutic levels of measured antiinfectiva
10 Recruiting Ultrasound of the Diaphragm in ICU Patients
Condition: Critically Ill
Intervention: Other: diaphragm ultrasound
Outcome Measure: Diaphragmatic dysfunction
11 Recruiting Non-sedation Versus Sedation With a Daily Wake-up Trial in Critically Ill Patients Receiving Mechanical Ventilation - Effects on Physical Function
Conditions: Critically Ill;   Muscular Atrophy
Interventions: Other: Non-sedation;   Other: Sedation, control
Outcome Measures: Physical function;   6 minute walk;   Handgrip;   Thigh muscle size;   Biomechanical data
12 Unknown † ICG- Livertest Versus New Biomarkers as Prognostic Markers in Critically Ill ICG- Livertest Versus New Biomarkers as Prognostic Markers in Critically Ill
Condition: Critically Ill Patients
Intervention: Procedure: Observational
Outcome Measure:
13 Recruiting Pharmacokinetics of Micafungin in Critically Ill Patients
Conditions: Critical Illness;   Invasive Candidiasis
Intervention:
Outcome Measures: Correlation of pharmacokinetic parameters/plasma concentrations of micafungin with disease severity.;   Pharmacokinetic parameters of micafungin in ICU patients.;   Time (in days) to culture conversion.;   Correlation of the plasma concentration of micafungin with response to treatment.;   Correlation of the plasma concentration of micafungin with inflammation parameters.;   Area under the concentration-time curve (AUC)/minimal inhibitory concentration (MIC) ratio.;   Composing a pharmacokinetic model of micafungin in critically ill patients.;   Highest observed plasma concentration (Cmax)/minimal inhibitory concentration (MIC) ratio.
14 Not yet recruiting Observational Prospective Study of the Predicted Value of Immature Thrombocytes Counts in Three Different Groups of Critically Ill Patients
Conditions: Critically Ill Patients;   Neutropenic Fever Patients;   Patients With Hip Fractures
Intervention: Other: Immature Platelet Fraction
Outcome Measures: Time to recovery from sepsis or time to death;   Predicting value of IPF for prognosis
15 Recruiting Predictors of Upper Airway Function and Sleep-disordered Breathing in the Critically Ill
Conditions: Critically Ill;   Obstructive Sleep Apnea
Interventions: Device: Ventilator;   Device: Alice PDx;   Other: Pulmonary function test;   Other: Muscle strength tests;   Other: Grip strength measurement;   Drug: Sedatives and muscle relaxants given in the ICU
Outcome Measure: Apnea-hypopnea index (AHI)
16 Not yet recruiting Optimal Protein Supplementation for Critically Ill Patients
Condition: Critical Illness
Intervention: Dietary Supplement: Beneprotein
Outcome Measures: Cumulative Organ failure free days;   Mortality
17 Not yet recruiting Bioavailability of Voriconazole
Conditions: Voriconazole;   Bioavailability;   Critically Ill
Intervention: Other: Dosage form of voriconazole
Outcome Measures: The bioavailability of voriconazole in critically ill patients;   Correlation of bioavailability of voriconazole with disease severity;   Correlation of bioavailability of voriconazole with the degree of inflammation
18 Recruiting Transfusion Requirements in Critically Ill Oncologic Patient
Condition: Anemia
Intervention: Biological: Red blood cell transfusion
Outcome Measures: To compare mortality between groups 28 day after ICU admission;   To compare length of stay in ICU between groups;   To compare length of stay in hospital between groups;   To compare days free of organ dysfunction between groups;   Adverse effects of transfusion;   Mortality;   All cause 90 day mortality All cause 90 day mortality Mortality
19 Recruiting Efficiency of a Small-peptide Enteral Feeding Formula Compared to a Whole-protein Formula
Conditions: Traumatic and/or Non-traumatic Brain Injury;   Critically Ill
Interventions: Dietary Supplement: Peptamen® AF;   Dietary Supplement: Sondalis® HP
Outcome Measures: the nutritional efficacy of a small-peptide (Peptamen AF®) to that of a whole-protein (Sondalis HP®) enteral feeding formula in traumatic and non-traumatic brain injured critically ill patients;   impact on morbidity and mortality of a small-peptide (Peptamen AF®) to that of a whole-protein (Sondalis HP®) enteral feeding formula.
20 Unknown † Hypocaloric Nutrition in Critically Ill Patients
Condition: Critically Ill
Interventions: Dietary Supplement: Hypocaloric hyperproteic nutrition;   Dietary Supplement: Standard care
Outcome Measures: SOFA (Sequential Organ Failure Assessment) score;   Insulin requirements